Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Apogee Therapeutics Inc’s current trading price is -34.96% away from its 52-week high, while its distance from the 52-week low is 111.80%. The stock’s price range during this period has varied between $22.20 and $72.29. The company, active in the Healthcare sector, saw a trading volume of around 0.58 million for the day, considerably higher average daily volume of 0.48 million observed over the last three months.
The stock market performance of Apogee Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $72.29 on 03/13/24, while the lowest price during the same time frame was $22.20, recorded on 12/20/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Apogee Therapeutics Inc (APGE) has experienced a quarterly decline of -19.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.75B.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 50.49, with a change in price of -0.88. Similarly, Apogee Therapeutics Inc recorded 441,912 in trading volume during the last 100 days, posting a change of -1.84%.
How APGE’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for APGE stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
APGE Stock Stochastic Average
As of today, the raw stochastic average of Apogee Therapeutics Inc over the past 50 days is 23.88%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 43.94%. Additionally, the Stochastic %K and %D values for the company were 40.37% and 40.55%, respectively, over the past 20 days.
APGE Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 68.29% this year. Over the last six months, there has been a weaker performance of 23.74%. The price of APGE fallen by 1.07% during the last 30 days period. For the last 5-days stocks have improved 6.09%.
